Literature DB >> 8637050

Second cancers after adjuvant tamoxifen therapy for breast cancer.

R E Curtis1, J D Boice, D A Shriner, B F Hankey, J F Fraumeni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8637050     DOI： 10.1093/jnci/88.12.832

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  27 in total

1.  Peroxidase-mediated dealkylation of tamoxifen, detected by electrospray ionization-mass spectrometry, and activation to form DNA adducts.

Authors:  Nilesh W Gaikwad; William J Bodell
Journal:  Free Radic Biol Med       Date:  2011-10-18       Impact factor: 7.376

2.  Genotoxicity of the some selective estrogen receptor modulators: a review.

Authors:  Serkan Yilmaz; Ilknur M Gönenç; Ebru Yilmaz
Journal:  Cytotechnology       Date:  2014-03-05       Impact factor: 2.058

3.  Risk of treatment-related esophageal cancer among breast cancer survivors.

Authors:  L M Morton; E S Gilbert; P Hall; M Andersson; H Joensuu; L Vaalavirta; G M Dores; M Stovall; E J Holowaty; C F Lynch; R E Curtis; S A Smith; R A Kleinerman; M Kaijser; H H Storm; E Pukkala; R E Weathers; M S Linet; P Rajaraman; J F Fraumeni; L M Brown; F E van Leeuwen; S D Fossa; T B Johannesen; F Langmark; S Lamart; L B Travis; B M P Aleman
Journal:  Ann Oncol       Date:  2012-06-27       Impact factor: 32.976

Review 4.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

Review 5.  Estrogen, male dominance and esophageal adenocarcinoma: is there a link?

Authors:  Huiqi Yang; Olga A Sukocheva; Damian J Hussey; David I Watson
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

6.  17β-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice.

Authors:  Alexander Sheh; Zhongming Ge; Nicola M A Parry; Sureshkumar Muthupalani; Julia E Rager; Arkadiusz R Raczynski; Melissa W Mobley; Amanda F McCabe; Rebecca C Fry; Timothy C Wang; James G Fox
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-16

7.  Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.

Authors:  Jieqiong Liu; Wen Jiang; Kai Mao; Yi An; Fengxi Su; Betty Y S Kim; Qiang Liu; Lisa K Jacobs
Journal:  Breast Cancer Res Treat       Date:  2015-03-13       Impact factor: 4.872

8.  Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy.

Authors:  Min Yi; Janice N Cormier; Yan Xing; Sharon Hermes Giordano; Christy Chai; Funda Meric-Bernstam; Georges Vlastos; Henry M Kuerer; Nadeem Q Mirza; Thomas A Buchholz; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2012-12-06       Impact factor: 5.344

9.  The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.

Authors:  M J E Mourits; K A Ten Hoor; A G J van der Zee; P H B Willemse; E G E de Vries; H Hollema
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

10.  Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium.

Authors:  Chang Mo Moon; Seok-Hyung Kim; Sang Kil Lee; Jiyeon Hyeon; Ja Seung Koo; Sangheun Lee; Jean S Wang; Won Jae Huh; Shradha S Khurana; Jason C Mills
Journal:  Dig Dis Sci       Date:  2013-12-25       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.